Musculoskeletal PainNCT06328595
Muscular and Joint Symptoms in COVID-19 Patients: Insights From Syria
An observational study of Musculoskeletal Pain and COVID-19, run by Syrian Private University at 1 site in Syria.
Trial summary
Observation study, shows the relation between musckeloskeletal symptoms with during and post Covid-19 infection, by asking participants questions about there age,job,which vaccination covid participants took, residual area, social status, number of time of covid-19 infection, number of joint affected and duration of… Read more about this study
- Who is it for?
- Ages 18 to 78 yearsHealthy volunteers can take part
- Conditions the study is for
- Musculoskeletal Pain, COVID-19
- How many people
- 1,039 participants
- Where
- 1 siteSyria
- Study dates
- 22 Apr 2022to 20 Aug 2023
- How long will I take part?
- 1 Day
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 78 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: We collected participants by google form in syria
Who may be able to join
- Participants aged ≥ 18 years with a prior COVID-19 infection or suspicious COVID-19 infection and currently residing in Damascus.
Who cannot join
- Participants below 18 years, those unwilling to give consent, individuals with joint surgery history, pregnant women, or those who had taken immunosuppressive drugs before the study.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: A Cross-Sectional Analysis of Muscular and Joint Symptoms in COVID-19 Patients: Insights From Syria
Observation study, shows the relation between musckeloskeletal symptoms with during and post Covid-19 infection, by asking participants questions about there age,job,which vaccination covid participants took, residual area, social status, number of time of covid-19 infection, number of joint affected and duration of joint pain and asking if there any malaise or fatigue
- Conditions
- Musculoskeletal Pain, COVID-19
- Keywords
- Fatigue, Joint pain, Covid-19 vaccination, Malaise
- Medical subject headings
- Musculoskeletal Pain, COVID-19, Fatigue, Arthralgia
What is being measured
The primary outcome is the main question the study is designed to answer.
The Demographic characteristics were classified into four groups: Gender, Residual area, education level.
Gender was either male or female. Residual area was divided into tow categories: Rural or City. Social status were divided into four types: Single, Married, Divorced, Widow .
Measured: The study took 6 months to finish it with hard work, it was hard to reach our participants so we didn't only collect our data from google form we also colleted our data from Al-Mouassa University Hospital outpatients clinics and Damascus University
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Mar 2024
- Study start22 Apr 2022
- Primary completion4 May 2023
- Study completion20 Aug 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Musculoskeletal PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 1,039 participants (actual)
- Target duration
- 1 Day
Sponsor and investigators
- Lead sponsor
- Syrian Private University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mohamad Zaid Mohamad Samer Ahmad Abdalla, Syrian Private University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06328595
- Sponsor's protocol ID
- Cross sectional
- Status last verified
- Mar 2024
- First submitted
- 22 Mar 2024
- Last updated
- 26 Mar 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 Mar 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Cross-Sectional Analysis of Muscular and Joint Symptoms in COVID-19 Patients: Insights From Syria
- ClinicalTrials.gov ID
- NCT06328595
- Acronym / sponsor ID
- Cross sectional
- Conditions
- Musculoskeletal Pain, COVID-19
- Keywords
- Fatigue, Joint pain, Covid-19 vaccination, Malaise
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,039 participants (actual)
- Lead sponsor
- Syrian Private UniversityUniversity, hospital or other
- Study start
- 22 Apr 2022 (actual)
- Primary completion
- 4 May 2023 (actual)
- Study completion
- 20 Aug 2023 (actual)
- First posted
- 25 Mar 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Observation study, shows the relation between musckeloskeletal symptoms with during and post Covid-19 infection, by asking participants questions about there age,job,which vaccination covid participants took, residual area, social status, number of time of covid-19 infection, number of joint affected and duration of joint pain and asking if there any malaise or fatigue
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Target follow-up
- 1 Day
Who may qualify
- Ages
- 18 to 78 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- We collected participants by google form in syria
Key inclusion criteria (1 listed)
- Participants aged ≥ 18 years with a prior COVID-19 infection or suspicious COVID-19 infection and currently residing in Damascus.
Key exclusion criteria (1 listed)
- Participants below 18 years, those unwilling to give consent, individuals with joint surgery history, pregnant women, or those who had taken immunosuppressive drugs before the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
The Demographic characteristics were classified into four groups: Gender, Residual area, education level.
Time frame: The study took 6 months to finish it with hard work, it was hard to reach our participants so we didn't only collect our data from google form we also colleted our data from Al-Mouassa University Hospital outpatients clinics and Damascus University
Gender was either male or female. Residual area was divided into tow categories: Rural or City. Social status were divided into four types: Single, Married, Divorced, Widow .
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Mar 2024.
Related trials for Musculoskeletal Pain
Recruiting
Effects of Cervicothoracic Mobilization in Patients With Supraspinatus Tendinitis
Rotator Cuff Tendonitis
Recruiting
Effects of Telerehabilitation Versus Supervised Rehabilitation Protocol on Pain, Range of Motion and Functional Recovery in Patients With Patellofemoral Pain Syndrome.
Patello Femoral Pain Syndrome
Recruiting
Hybrid mHealth and Telerehabilitation vs Conventional Physiotherapy for Subacromial Pain Syndrome
Subacromial Pain Syndrome
Active, not recruiting
Objective Measurement of Pain Regulation in Individuals Who Have Received Internet-delivered Exposure-based Cognitive Behavior Therapy
Fibromyalgia
RecruitingPhase 4
Efficacy of Ketorolac for Postoperative Pain Management in Hip Arthroscopy
Femoracetabular Impingement, Hip Arthroscopy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Musculoskeletal Pain and COVID-19, run by Syrian Private University at 1 site in Syria.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Syria. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The Demographic characteristics were classified into four groups: Gender, Residual area, education level. (time frame: The study took 6 months to finish it with hard work, it was hard to reach our participants so we didn't only collect our data from google form we also colleted our data from Al-Mouassa University Hospital outpatients clinics and Damascus University). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Mar 2024.